EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma

Shuomeng Du, Han Qu, Ying Zhang, Shihao Zhu, Yang Wang, Shuopeng Zhang, Zhao Wang, Qian Yang, Songbin Fu, Kexian Dong

Pathology - Research and Practice · 2023

DOI: 10.1016/j.prp.2023.154765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Shuomeng Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, Harbin 150…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Harbin Medical University, Postdoctoral Scientific Research Development Fund of Heilongjiang Province, Ministry of Education of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cisplatin-based chemotherapy has been widely used in the treatment of lung adenocarcinoma (LUAD). However, the development of cisplatin resistance becomes a major obstacle impeding the curative effect. It remains necessary to uncover the molecular mechanism of cisplatin resistance. METHODS: Based on the CCLE database, lung cancer cell lines were divided into cisplatin-resistant and cisplatin-sensitive groups. The differentially expressed miRNAs were filtered and further identified by survival prognosis analysis. After transfection with miR-375 inhibitor or mimic, cell cytotoxicity assay, flow cytometry and western blot were conducted to validate the role of miR-375. The transcription factor (TF)-miRNA network was constructed based on TransmiR. The target genes of miR-375 were predicted by Starbase and further verified by RT-qPCR and immunohistochemistry results in the Human Protein Atlas. Functional enrichment analysis was performed with GO terms and KEGG. RESULTS: In this study, miR-375 showed the ability to promote cisplatin sensitivity and apoptosis of LUAD. Genes correlated with miR-375 in LUAD were analyzed and ABCC8 showed the strongest positive correlation. Moreover, transcription factors that regulate miR-375 expression were predicted. MBNL1, PTPN3, PRKD1 and RPN1 were identified as the target genes of miR-375. Enrichment analysis demonstrated that miR-375-related genes associated with promoting cell proliferation and anti-apoptosis were involved in the MAPK signaling pathway. CONCLUSION: Overall, this study provides new insights into the role of miR-375 in the cisplatin sensitivity of LUAD. Our present findings may serve as a theoretical basis for new therapeutic strategies and predictive models of cisplatin resistance in LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsMicroRNAsHumansCisplatinApoptosis

Stichwörter der Autor:innen

CisplatinDrug sensitivityLung adenocarcinomaMAPK pathwayMiR-375

Substanzen

CisplatinMicroRNAsMIRN375 microRNA, human

Autor:innen und Institutionen

  • Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, Harbin 150081, China; Laboratory of Medical Genetics, Harbin Medical University,…
  • Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin 150081, China.

Förderung

  • Harbin Medical University
  • Postdoctoral Scientific Research Development Fund of Heilongjiang Province
  • Ministry of Education of the People's Republic of China

Zitieren

APA

Du, S., Qu, H., Zhang, Y., Zhu, S., Wang, Y., Zhang, S., Wang, Z., Yang, Q., Fu, S., & Dong, K. (2023). MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154765

Vancouver

Du S, Qu H, Zhang Y, Zhu S, Wang Y, Zhang S, et al. MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154765

BibTeX
@article{Du2023,
  author = {Du, Shuomeng and Qu, Han and Zhang, Ying and Zhu, Shihao and Wang, Yang and Zhang, Shuopeng and Wang, Zhao and Yang, Qian and Fu, Songbin and Dong, Kexian},
  title = {MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma},
  journal = {Pathology - Research and Practice},
  year = {2023},
  doi = {10.1016/j.prp.2023.154765}
}
Kostenlos starten →